Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Suzetrigine vs Usual-care Opioids for Postoperative Pain After ACL Reconstruction
NCT07355166Phase 4Not yet recruiting
- Sponsor
- University of California, Los Angeles
- Start
- Sep 2026
- Primary completion
- Jan 2027
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of suzetrigine in postoperative pain, sponsored by University of California, Los Angeles. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
suzetrigine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT07355166.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07355166.